MEI Pharma commits $100M to Litecoin with Charlie Lee joining its board, signaling major institutional interest in LTC.

MEI Pharma, a publicly traded pharmaceutical company, closed a $100 million private placement to turn itself into a litecoin ...

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

In a bold move that’s redefining crypto’s relationship with traditional finance, MEI Pharma, a Nasdaq-listed company known ...

MEI Pharma’s $100M Litecoin purchase fuels a 100% stock surge, marking a groundbreaking move in crypto treasury strategy.

MEI Pharma (NASDAQ:MEIP) has launched a $100 million Litecoin (CRYPTO: LTC) treasury program, backed by Titan Partners Group ...

MEI Pharma announces a $100 million private placement to adopt Litecoin as its primary treasury reserve asset.

Charlie Lee and GSR acted as lead investors, alongside participation from the Litecoin Foundation and prominent crypto ...

A little-known Nasdaq-listed drugmaker plans to invest $100M in litecoin, appoints Charlie Lee to its board and names GSR as ...

MEI Pharma unveils bold $100M Litecoin treasury plan with Titan, GSR, Litecoin Foundation, expanding altcoin adoption beyond ...

GSR announced an investment and strategic partnership with MEI Pharma in which it will serve as both strategic advisor and ...

MEI Pharma ( (MEIP)) has issued an update. On July 17, 2025, MEI Pharma entered into securities purchase agreements for a private placement offering, raising approximately $100 million to initiate a ...